Holen Sie sich die Stockscreener-App
4.49
0.00%
0.00
Schlusskurs vom Vortag:
$4.49
Offen:
$4.49
24-Stunden-Volumen:
35,034
Relative Volume:
0.39
Marktkapitalisierung:
$116.43M
Einnahmen:
$40,000
Nettoeinkommen (Verlust:
$-38.64M
KGV:
-2.4384
EPS:
-1.8414
Netto-Cashflow:
$-22.21M
1W Leistung:
+1.58%
1M Leistung:
-1.32%
6M Leistung:
-55.10%
1J Leistung:
-7.99%
1-Tages-Spanne:
$4.37
$4.515
1-Wochen-Bereich:
$4.26
$4.5399
52-Wochen-Spanne:
$3.69
$12.99
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
Firmenname
Neonc Technologies Holdings Inc
Sektor
Branche
Telefon
310 663 7831
Adresse
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
4.49 | 116.43M | 40,000 | -38.64M | -22.21M | -1.8414 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Neonc Technologies Holdings Inc Aktie (NTHI) Neueste Nachrichten
NeOnc Technologies Holdings, Inc. (NTHI) 8-K Filing: Director and Officer Changes Announced – Nasdaq Emerging Growth Company Update – Minichart - Minichart
NeOnc Technologies Adds New Director Amid Governance Focus - TipRanks
New NeOnc (NASDAQ: NTHI) director is CEO's niece - Stock Titan
NeOnc Technologies Holdings, Inc. Financial Disclosures & SEC Filings - TradingView
NeOnc Technologies Holdings (NTHI) Investor Relations, Earnings Summary & Outlook - Quartr
NeOnc Technologies Holdings, Inc. (NTHI) Stock Price, News, Quote & History - Yahoo! Finance Canada
NeOnc Technologies Holdings, Inc.(NasdaqGM:NTHI) dropped from Russell 3000E Growth Benchmark - marketscreener.com
NeOnc Technologies Holdings, Inc.(NasdaqGM:NTHI) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
NTHI Q1 2026 Earnings: EPS Misses Estimates as Company Focuses on Pipeline DevelopmentEarnings Expansion Phase - dars.gov.et
NTHI Forecast — Price Target — Prediction for 2027 - TradingView
NeOnc Technologies Holdings, Inc. Actuals & Estimates (NASDAQ:NTHI) - TradingView
NeOnc Technologies Holdings, Inc. Actuals & Estimates (BOATS:NTHI) - TradingView
NeOnc Technologies Holdings, Inc. announced that it has received $5.00004 million in funding - marketscreener.com
NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum - The Manila Times
NeOnc Technologies Holdings Secures Second UAE IND Authorization for NEO100, Expanding Global CNS Cancer Development Program - Moomoo
[EFFECT] NEONC TECHNOLOGIES HOLDINGS, INC. SEC Filing - Stock Titan
NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone - Sahm
Form 424B5 Neonc Technologies Holdings Inc For: 23 June By Investing.com - Investing.com India
NeOnc wins another UAE clearance as brain-cancer data nears - Stock Titan
Form DEF 14A NEONC TECHNOLOGIES HOLDINGS For: 23 June By Investing.com - Investing.com South Africa
NeOnc Wins Abu Dhabi IND Clearance for NEO100 - TipRanks
NeOnc Technologies (NASDAQ: NTHI) details 2026 virtual meeting, board elections and plan changes - Stock Titan
NeOnc Technologies Receives UAE IND for NEO100, Phase 2a Readout Expected by End of July - TradingView
NeOnc Technologies (Nasdaq: NTHI) wins UAE IND for NEO100 ahead Phase 2a data - Stock Titan
NeOnc (NTHI) registers 555,554 shares for resale, includes 277,777‑share warrant - Stock Titan
NeOnc receives UAE approval for NEO100 glioma drug trials By Investing.com - Investing.com South Africa
NeOnc receives UAE approval for NEO100 glioma drug trials - Investing.com
NeOnc Technologies Receives UAE IND Approval for NEO100, - GlobeNewswire
NeOnc Secures Abu Dhabi IND Authorization for NEO212 - Intellectia AI
WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy - TMX Newsfile
NTHI Q1 2026 Earnings: Wider-than-Expected Loss as EPS Misses EstimatesEarnings Growth Analysis - dars.gov.et
NeOnc Technologies Secures UAE IND Approval for NEO212, Advancing Global Phase 2 Trials for Aggressive Brain Tumors - Minichart
NeOnc Wins UAE IND Clearance for NEO212 Brain Therapy - TipRanks
NeOnc secures Abu Dhabi IND for NEO212, clears path to Phase 2 at 610 mg - TradingView
NTHI - Finviz
NeOnc Technologies Holdings Inc (NTHI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NeOnc Technologies Holdings Inc - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Institutional Confidence - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Valuation: PE, PB & Fair Value Analysis - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212 - The Manila Times
Brain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND - The Manila Times
NeOnc's Global Gambit: Abu Dhabi Nod Accelerates Brain Cancer Attack - BriefGlance
Top Biotech Gainers: CRVO On Watch, SLP Scooped Up, LNAI Back In Compliance, NTHI Advances NEO212 - RTTNews
NeOnc Technologies Holdings Secures IND Authorization for NEO212, Advancing Clinical Programs for Aggressive Brain Cancers - Quiver Quantitative
Neonc Technologies Secures UAE IND Approval For NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development - Mena FN
NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development - Asianet Newsable
Finanzdaten der Neonc Technologies Holdings Inc-Aktie (NTHI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Neonc Technologies Holdings Inc-Aktie (NTHI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Heshmatpour Amir F | President |
Apr 28 '26 |
Buy |
4.52 |
10,000 |
45,180 |
3,062,000 |
| Neman-Ebrahim Yousha | Chief Clinical Officer |
Apr 23 '26 |
Buy |
4.88 |
500 |
2,440 |
134,760 |
| Heshmatpour Amir F | President |
Apr 23 '26 |
Buy |
4.90 |
10,000 |
49,000 |
3,052,000 |
| SUH, DAVID JR. | Chief Accounting Officer |
Apr 09 '26 |
Buy |
5.00 |
200 |
1,000 |
111,866 |
| Heshmatpour Amir F | President |
Apr 10 '26 |
Buy |
4.89 |
10,000 |
48,950 |
3,042,000 |
| Heshmatpour Amir F | President |
Apr 08 '26 |
Buy |
5.61 |
10,000 |
56,050 |
3,027,000 |
| Heshmatpour Amir F | President |
Apr 09 '26 |
Buy |
5.19 |
5,000 |
25,950 |
3,032,000 |
| Heshmatpour Amir F | President |
Apr 02 '26 |
Buy |
6.09 |
20,000 |
121,798 |
3,012,000 |
| Heshmatpour Amir F | President |
Apr 06 '26 |
Buy |
6.32 |
5,000 |
31,600 |
3,017,000 |
| Heshmatpour Amir F | President |
Nov 21 '25 |
Buy |
6.07 |
24,000 |
145,600 |
2,986,000 |
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):